EGFR and chronic obstructive pulmonary disease: In the present study, we observed significantly decreased levels of phosphorylated EGFR and significant increased levels of phosphorylated p38, ERK, and JNK in the disease model group indicating that the EGFR/MAPK pathway is activated in COPD rats.